Fluticasone propionate/formoterol: A fixed-combination therapy with flexible dosage

Nicola Scichilone, Pierluigi Paggiaro, Andrea Rossi, Cazzola, Giorgio Walter Canonica, Andrea S. Melani, Blasi, Nicola Scichilone, Maria Pia Foschino Foschino Barbaro, Centanni, Fabio L.M. Ricciardolo, Alberto Papi

Risultato della ricerca: Articlepeer review

6 Citazioni (Scopus)


International guidelines describe asthma control as the main outcome of asthma management. Prevention of symptoms, improved quality of life, and reduction of exacerbations are the main components, consequently decreasing health care costs. However, many of these objectives remain unmet in real life: several surveys show that a large proportion of asthmatic patients are not well controlled despite the efficacy of current available treatment. Several randomized controlled clinical trials indicate that combining inhaled corticosteroids and long-acting β2-agonists, by means of a single inhaler, greatly improves the management of the disease. The results of 9 multicenter phase III clinical studies demonstrate that the fixed combination of fluticasone propionate/formoterol in a single inhaler is effective in terms of lung function and symptom control. These studies highlight the dose flexibility, safety and tolerability of this new inhaled combination. These characteristics meet the recommendations of international guidelines, and the preferences of respiratory physicians who identified these aspects as critical components of a successful asthma therapy. Combination of fluticasone propionate/formoterol in a single inhaler provides potent anti-inflammatory activity of fluticasone propionate and rapid onset of action of the β2-agonist formoterol making this association a viable treatment option both in terms of effectiveness and compliance.
Lingua originaleEnglish
Numero di pagine9
RivistaEuropean Journal of Internal Medicine
Stato di pubblicazionePublished - 2014

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2724???


Entra nei temi di ricerca di 'Fluticasone propionate/formoterol: A fixed-combination therapy with flexible dosage'. Insieme formano una fingerprint unica.

Cita questo